CFO transition
Vir Biotechnology, Inc. CFO transition: Aziz Sawaf, MBEE, MBA, CFA to succeed Brent Sabatini, CPA, MBA
Vir Biotechnology, Inc. reported in a Form 8-K filed October 1, 2026 that Aziz Sawaf, MBEE, MBA, CFA will succeed Brent Sabatini, CPA, MBA as Executive Vice President and Chief Financial Officer, effective October 5, 2026.
In the filing's words
Aziz Sawaf, MBEE, MBA, CFA has been appointed as Executive Vice President and Chief Financial Officer and “principal financial officer” of the Company, effective as of October 5, 2026 (the Effective Date).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Vir Biotechnology, Inc. (VIR) |
|---|---|
| Event | Transition |
| Incoming | Aziz Sawaf, MBEE, MBA, CFA |
| Outgoing | Brent Sabatini, CPA, MBA |
| Title in the filing | Executive Vice President and Chief Financial Officer |
| Effective | October 5, 2026 |
| 8-K filed | October 1, 2026 |
| Internal promotion | Not established by the source |
| SEC CIK | 0001706431 |
Vir Biotechnology, Inc. reported this change in a Form 8-K, Item 5.02, filed October 1, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-01
Something wrong about Aziz Sawaf, MBEE, MBA, CFA? Send a correction with the primary source.